NORWOOD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today anno
MariMed Inc. (MRMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NORWOOD, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- InHouse™ announced today the launch of its second annual Help on the Homefront campaign, a philanthropic effort that provides veterans the chance to
MariMed will report its third quarter 2025 financial results on November 5, 2025 and conduct its analyst conference call on November 6, 2025, at 8am ET.
NORWOOD, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Betty's Eddies™ announced its third annual collaboration with the Keep A Breast Foundation (“KAB”), furthering its commitment to breast cancer
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, MariMed Inc. (MRMD) could be a great choice. It is one of the several stocks that pa
MariMed Inc. (MRMD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks th
MariMed Inc. (MRMD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still t
The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.
MariMed Inc. (OTCQX:MRMD) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Jake Dean - Director of Research and Development Jon R. Levine - Co-Founder, CEO, President, S

MariMed (MRMD) Q2 EPS Jumps to Positive

12:11am, Thursday, 07'th Aug 2025
MariMed (MRMD) Q2 EPS Jumps to Positive
MariMed Inc. (MRMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to break-even earnings per share a year ago.

MariMed Reports Second Quarter 2025 Earnings

05:00pm, Wednesday, 06'th Aug 2025
NORWOOD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every
NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today anno
NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Sto
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE